Disease definition: Pneumococcal polysaccharide vaccine (PPSV)—the latest version is known as Pneumovax 23 (PPV-23)—is the first pneumococcal vaccine, the first vaccine derived from a capsular polysaccharide, and an important landmark in medical history. The polysaccharide antigens were used to induce type-specific antibodies that enhanced opsonization, phagocytosis, and killing of Streptococcus pneumoniae (pneumococcal) bacteria by phagocytic immune cells.
Symptoms: "Less serious side effects are more likely to occur, such as: low fever (102 degrees or less), chills, tired feeling; swelling, pain, tenderness, or redness anywhere on your body; headache, nausea, vomiting; joint or muscle pain; swelling or stiffness in the arm or leg the vaccine was injected into; mild skin rash."
Disease Treatment: " Antibiotics can be used for treatment. However, some pneumococcal bacteria have become “antibiotic resistant” and antibiotics no longer kill them. Antibiotic resistance makes it very hard to treat some pneumococcal infections.
Statistics:"Death rate of Pneumococcal (Pneumococcal Polysaccharide Vaccine)patients per 100,000 was found to be 1.21% during the year 2014 "